Manufacturing Sites - Lupin
Our manufacturing footprint — 15 world-class facilities spread across India, the U.S., Brazil and Mexico — are designed to deliver the promise of caring that Lupin has come to symbolise – …
Lupin’s Goa Manufacturing Plant Receives EIR from US FDA - Lupin
Mumbai, December 14, 2021:Global pharma major Lupin Limited (Lupin) today announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug …
Lupin Announces Resolution of USFDA Warning Letter for its Goa …
Mumbai, July 27, 2023: Global pharma major Lupin Limited (Lupin) today announced that it has received correspondence from the US FDA that it has now addressed the concerns raised in …
USFDA Warning Letter resolved: Lupin, Goa, Pithampur
Jul 29, 2023 · Lupin, a leading pharmaceutical company, has successfully addressed the concerns raised in the U.S. Food and Drugs Administration (USFDA) warning letter for its …
Lupin’s Goa manufacturing plant receives EIR from US FDA
Dec 17, 2021 · Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (US …
Lupin gets these 7 observations from USFDA for Goa Plant
Sep 23, 2021 · Pharma-major Lupin has received seven observations from the USFDA after the latter carried an inspection at the company’s Goa facility in India. The US health regulator …
Lupin : December 14, 2021 Lupin’s Goa Manufacturing Plant Receives EIR ...
Mumbai, December 14, 2021: Global pharma major Lupin Limited (Lupin) today announced that it has received the Establishment Inspection Report (EIR) from United States Food and Drug …
lupin: Lupin says USFDA warning on Goa and Pithampur facilities …
Jul 27, 2023 · Lupin on Thursday said it has received correspondence from the USFDA that it has now addressed the concerns raised in the Warning Letter for its facilities in Goa and …
Lupin’s Goa manufacturing plant gets EIR from US FDA
Dec 14, 2021 · Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Goa manufacturing …
Lupin's Goa plant gets 7 observations from USFDA, firm unperturbed
Sep 19, 2021 · Mumbai-based drugmaker said on Sunday that its Goa facility has received seven observations from the US drug regulator. At present, five sites of Lupin either have warning …